Recent
Articles:
|
1 |
Leblebicioglu
H, Turan D, Eroglu C, Esen S, Sunbul M, Bostanci F. A Cluster of anthrax cases
including meningitis. Tropical Doctor 2006;36(1):51-3.
PMID: 16483440 [PubMed - indexed for MEDLINE] |
|
2 |
Leblebicioglu
H, Yilmaz H, Tasova Y, Alp E, Saba R, Caylan R, Bakir M, Akbulut A, Arda B,
Esen S and Study Group (Cagatay A,
Ergin F, Bodur H, Sahin GS, Sencan I, Gurcan S, Doyuk E, Mete B, Oncul
O). Characteristics and analysis of risk factors for mortality in
infective endocarditis. Eur J
Epidemiol 2006;21(1):25-31. PMID: 16450203
[PubMed – indexed for MEDLINE] |
|
3 |
Kolayli
F, Gacar G, Karadenizli A, Sanic A, Vahaboglu H, The Study Group (Akan OA,
Kocazeybek B, Sumerkan B, Caylan R, Kurt H, Leblebicioglu H, Ulusoy S.)
PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa
and Acinetobacter spp. FEMS Microbiol
Lett 2005; 249 (2): 241-245. PMID: 16006075 [PubMed - indexed for
MEDLINE] |
|
4 |
Usluer
G, Ozgunes I, Leblebicioglu H and Turkish Antibiotic Utilization Study Group
(Akalın H, Ayaz C, Caylan R, Cetinkaya Sardan
Y, Demirturk N, Erdem I, Ergin F, Erol S, Esen S, Gündes S, Koksal I, Oncul
O, Ozdamar K, Ozturk R, Sirmatel F, Sencan I, Tasova Y, Erdem GT, Ulusoy S,
Unal S, Vahaboglu H, Yamazhan T). A multicenter point-prevalence study:
antimicrobial prescription frequencies in hospitalized patients in |
|
5 |
Sencan
I, Sahin I, Tuzuner T, Ozdemir D, Yildirim M, Leblebicioglu
H. In vitro bacterial adherence to
teicoplanin and calcium sulfate-soaked bone cement. J Chemother 2005;
17(2):174-8. PMID: 15920902 [PubMed - indexed for MEDLINE] |
|
6 |
Bakir
M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran M, Vahaboglu H, Turkish CCHF
Study Group (Elaldi N, Yilmaz N, Cevik
MA, Tulek N, Kubar A, Akın L, Leblebicioglu H, Yucaokur AA, Ozturk R, Vahaboglu
H,). Crimean-Congo
haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of
clinical features and outcome measures.
J Med Microbiol 2005;54:385-389. PMID:
15770025 [PubMed - indexed for MEDLINE] |
|
7 |
Sunbul
M, Leblebicioglu H, and Hepatitis Study Group. Distribution of hepatitis B virus genotypes
in patients with chronic hepatitis B in |
|
8 |
Sunbul
M, Atilla A, Esen S, Eroglu C, Leblebicioglu H. Thwaites' diagnostic
scoring and the prediction of tuberculous meningitis. Med Princ Pract 2005;14(3):151-4. PMID: 15863987 [PubMed - indexed for
MEDLINE] |
|
9 |
Canbaz
S, Sunter AT, Peksen Y, Leblebicioglu H. Survey of general practitioners'
knowledge about Helicobacter pylori infection. BMC Gastroenterol 2005; 5 (1): 4. PMID:
15673470 [PubMed - indexed for MEDLINE] |
|
10 |
Leblebicioglu
H, Sanic A, Esen S, Sunbül M. Clinical
microbiological case: a patient with icter and renal insufficiency. Case Rep Clin Rev 2004;5:545-547. |
|
11 |
Leblebicioglu
H, Sunbul M. Leptospiral infection and seropositivity in rodents. Prev Vet Med 2004; 65 (1-2): 117-118. PMID:
15454331 [PubMed - indexed for MEDLINE] |
|
12 |
Esen
S, Sunbul M, Leblebicioglu H, Eroglu C, Turan D.Impact of clinical and
laboratory findings on prognosis in leptospirosis. Swiss Med Wkly. 2004 Jun
12;134(23-24):347-52. |
|
13 |
Leblebicioglu
H, Eroglu C; Members of the Hepatitis Study Group. Acute hepatitis B
virus infection in |
|
14 |
Eroglu C, Leblebicioglu H, Gunaydin M,
Turan D, Sunbul M, Esen S, Sanic A. Distinguishing
hepatitis B virus (HBV) genotype D from non-D by a simple PCR. J Virol
Methods. 2004 Aug;119(2):183-7. |
|
15 |
Leblebicioglu
H. Antimicrobial treatment of ventilator-associated pneumonia. |
|
16 |
Esen
S, Leblebicioglu H. and Study Group. Prevalence of nosocomial infections
at intensive care units in |
|
17 |
Peksen
Y, Canbaz S, Leblebicioglu H, Sunbul M, Esen S, Sunter AT. Primary care
physicians' approach to diagnosis and treatment of hepatitis B and hepatitis
C patients. BMC Gastroenterol. 2004 Feb 06;4(1):3. |
|
Leblebicioglu H, Sunbul M, Esen S,
Eroglu C. Jarisch-Herxheimer reaction in
leptospirosis. Eur J Clin Microbiol Infect Dis. 2003 Oct; 22(10): 639; author
reply 640. Epub 2003 Sep 12. No abstract available. |
|
|
19 |
Leblebicioglu
H. Ref.: Penicillin at the late stage of leptospirosis: a randomized
controlled trial. Rev Inst Med Trop Sao Paulo. 2003 Jul-Aug; 45(4): 237;
author reply 238. Epub 2003 Sep 17. No abstract available. |
|
20 |
Leblebicioglu
H. Clinical aspects of chronic hepatitis C infection. JAMA. 2003 Sep 17;
290(11): 1453; author reply 1453-4. No abstract available. |
|
21 |
Leblebicioglu
H, Akbulut A, Ulusoy S, Sunbul M, Aydin K, Geyik MF, Esen S, Eroglu C.
Informal consultations in infectious diseases and clinical microbiology
practice. Clin Microbiol Infect. 2003 Jul; 9(7): 724-6. |
|
22 |
Karadenizli
A, Kolayli F, Okay E, Ergen K, Oz S, Savli H, Leblebicioglu H, Vahaboglu H.
Resistance emergence among P. aenrginosa in a rat thigh-abscess model.
Comparison of imipenem and meropenem treatment. New Microbiol. 2003 Jul;
26(3): 275-80. |
|
23 |
Leblebicioglu H, Turan D, Sunbul
M, Esen S, Eroglu C. Transmission of human immunodeficiency virus
and hepatitis B virus by blood brotherhood rituals.Scand J Infect Dis. 2003;35(3):210. |
|
24 |
Leblebicioglu
H, Esen S; Turkish Nosocomial Urinary Tract Infection Study Group.
Hospital-acquired urinary tract infections in |
|
25 |
Leblebicioglu H, Sunbul M. Leptospirosis:
Diagnosis and treatment. Infectious Disease Practice for Clinicians 2003; 27
(1): 171-174. |
|
26 |
Leblebicioglu H, Hokelek M,
Brook I. Toxoplasmosis. eMedicine Journal
2003;4:1. |
|
27 |
Esen
S, Leblebicioglu H, Sunbul M, Eroglu C, Leblebcioglu H. Repeated relapses
in a meropenem-treated Pseudomonas aeruginosa meningitis. |
|
28 |
Canbaz
S, Peksen Y, Tevfik Sunter A, Leblebicioglu H, Sunbul M. Antibiotic
prescribing and urinary tract infection. Int J Antimicrob Agents. 2002 Dec;20(6):407-11. |
|
29 |
Turgut
M, Sunbul M, Bayirli D, Bilge A, Leblebicioglu H, Haznedaroglu I.
Thrombocytopenia complicating the clinical course of leptospiral infection. J
Int Med Res. 2002 Sep-Oct;30(5):535-40. |
|
30 |
Leblebicioglu
H, Bayirli D, Esen S, Sunbul M, Eroglu C. Treatment of acute hepatitis C
virus infection with interferon-alpha 2b and ribavirin: Case report and
review of the literature. Ann Clin Microbiol Antimicrob. 2002 Oct 14 [Epub
ahead of print] |
|
31 |
Akcam
Z, Sunbul M, Durupinar B, Eroglu C, Esen S, Leblebicioglu H. Tissue types
as prognostic risk factor in hepatitis B virus infection. Indian J
Gastroenterol. 2002 Jul-Aug;21(4):139-41. |
|
32 |
Cengiz K, Uahan C, Sunbul M,
Leblebicioglu H, Cuner E. Acute renal
failure in leptospirosis in the black-sea region in Turkey. Int Urol Nephrol.
2002;33(1):133-6. |
|
33 |
Leblebicioglu H, Canbaz S, Peksen Y,
Gunaydin M. Physicians' antibiotic prescribing
habits for upper respiratory tract infections in Turkey. |
|
34 |
Leblebicioglu
H, Gunaydin M, Esen S, Tuncer I, Findik D, Ural O, Saltoslu N, Yaman A,
Tasova Y; Study Group. Surveillance of antimicrobial resistance in
gram-negative isolates from intensive care units in |
|
35 |
Leblebicioglu
H, Unal S. The organization of hospital infection control in |
|
36 |
Leblebicioglu H, Brook I.
Influenza. eMedicine Journal 2002;3:8. |
|
37 |
Sunbul
M, Esen S, Leblebicioglu H, Hokelek M, Pekbay A, Eroglu C. Rattus
norvegicus acting as reservoir of leptospira interrogans in the Middle Black
Sea region of Turkey, as evidenced by PCR and presence of serum antibodies to
Leptospira strain. Scand J Infect Dis. 2001;33(12):896-8.
|
|
38 |
Vahaboglu
H, Coskunkan F, Tansel O, Ozturk R, Sahin N, Koksal I, Kocazeybek B,
Tatman-Otkun M, Leblebicioglu H, Ozinel MA, Akalin H, Kocagoz S, Korten V.
Clinical importance of extended-spectrum beta-lactamase
(PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains.
J Med Microbiol. 2001 Jul;50(7):642-5. |
|
39 |
Over
U, Gur D, Unal S, Miller GH; Aminoglycoside Resistance Study Group. The
changing nature of aminoglycoside resistance mechanisms and prevalence of
newly recognized resistance mechanisms in |
|
40 |
Sunbul M, Barut S, Esen S, Eroglu C,
Leblebicioglu H. Corynebacterium citriatum Meningitis: Report of Two Adult
Cases. Microbial Ecology in Health and Diseases 2000;12:57-59. |
|
41 |
Sunbul
M, Leblebicioglu H, Esen S, Eroglu C, Barut S. Response to hepatitis B
vaccine in HBsAg/anti-HBs negative and anti-HBc positive subjects. Scand J
Infect Dis. 2000;32(3):315-6. |
|
42 |
Aksaray
S, DokuzoGuz B, Guvener E, Yucesoy M, Yulug N, Kocagoz S, Unal S, Cetin S,
Calangu S, Gunaydin M, Leblebicioglu H, Esen S, Bayar B, Willke A, Findik D,
Tuncer I, Baysal B, Gunseren F, Mamikoglu L. Surveillance of
antimicrobial resistance among gram-negative isolates from intensive care
units in eight hospitals in Turkey. J Antimicrob Chemother. 2000 May;45(5):695-9. Erratum in: J Antimicrob Chemother 2000 Oct;46(4):649. |
|
43 |
Yucesoy M, Yulug N, Kocagoz S,
Unal S, Cetin S, Calangu S. Antimicrobial
resistance of gram-negative isolates from intensive care units in |
|
44 |
Willke
A, Arman D, Cokca F, Sumerkan B, Soyletir G, Bakir M, Sirmatel F,
Leblebicioglu H, Kijlijc S. Resistance of Salmonella and Shigella in
Turkey. |
|
45 |
Leblebicioglu
H, Nas Y, Eroglu C, Sunbul M, Esen S, Gunaydin M. Detection of extended
spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae. J
Chemother. 1999 Apr;11(2):103-6. |
|
46 |
Gunseren
F, Mamikoglu L, Ozturk S, Yucesoy M, Biberoglu K, Yulug N, Doganay M,
Sumerkan B, Kocagoz S, Unal S, Cetin S, Calangu S, Koksal I, Leblebicioglu H,
Gunaydin M. A surveillance study of antimicrobial resistance of
gram-negative bacteria isolated from intensive care units in eight hospitals
in Turkey. J Antimicrob Chemother. 1999 Mar;43(3):373-8.
|
|
47 |
Leblebicioglu
H, Sencan I, Gunaydin M, Esen S, Eroglu C, Sunbul M. Elution of
vancomycin and tobramycin bonded to vascular grafts. J Chemother. 1999 Feb;11(1):46-9. |
|
48 |
Pfaller
MA, Korten V, Jones RN, Doern GV. Multicenter evaluation of the
antimicrobial activity for seven broad-spectrum beta-lactams in |
|
49 |
Sunbul M, Eroglu C, Akcam Z, Adam B,
Ozdener H, Leblebicioglu H. Serum Thymidine Kinase Levels In Patients With
Acute Viral Hepatitis A and B. Bulletin of the Osaka Medical College
1999;45(1):1-3. |
|
50 |
Vahaboglu
H, Ozturk R, Aygun G, Coskunkan F, Yaman A, Kaygusuz A, Leblebicioglu H,
Balik I, Aydin K, Otkun M. Widespread detection of PER-1-type
extended-spectrum beta-lactamases among nosocomial Acinetobacter and
Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study.
Antimicrob Agents Chemother. 1997 Oct;41(10):2265-9.
Erratum in: Antimicrob Agents Chemother 1998 Feb;42(2):484.
|
|
51 |
Leblebicioglu H,
Sunbull M, Esen S, Günaydin M. Acute Hepatitis A Virus Infection and
Meningoencephalitis. Annals of Saudi Medicine 1997;17:86-87. |
|
52 |
Leblebicioglu H, Sanic A, Gunaydin
M, Sencan I, Dabak N, Nas Y. In-vitro
release of vancomycin and netilmicin from bone cement. Clin Microbiol Infect.
1996 Mar;1(3):211-212. No abstract available. |
|
53 |
Leblebicioglu
H, Sencan I, Sunbul M, Altintop L, Gunaydin M. Weil's disease: report of
12 cases. Scand J Infect Dis. 1996;28(6):637-9. |
|
54 |
Leblebicioglu H, Esen S, Bedir A,
Gunaydin M, Sanic A. The validity
of Spanos' and Hoen's models for differential diagnosis of meningitis. Eur J
Clin Microbiol Infect Dis. 1996 Mar;15(3):252-4. No
abstract available. |
|
55 |
Durupinar B, Gunaydin M, Sanic A,
Pirincciler M, Leblebicioglu H. In Vitro Susceptibility of Yeast Isolates
from Various Clinical Specimens to Antifungal Agents. Mikol Lek 1996;3(1):1-4. |
Contact Information:
Prof. Hakan Leblebicioglu, MD
Department of Clinical Microbiology and Infectious Diseases, Chief
Tel: +90 (362) 4576000/2480
Fax: +90 (362) 4576029
[ Home | Up | Next ]
Copyright © 1997 Hakan Leblebicioglu
Revised: May 10, 2006